Key regions: Australia, Germany, United Kingdom, United States, France
The demand for immunosuppressants in Angola has been on the rise in recent years.
Customer preferences: The increase in demand for immunosuppressants in Angola can be attributed to the rise in chronic diseases, such as diabetes and hypertension, which require long-term treatment. Additionally, there has been an increase in the number of organ transplant surgeries in the country, which has also contributed to the growth of the immunosuppressants market.
Trends in the market: One of the trends in the immunosuppressants market in Angola is the shift towards the use of generic drugs. This is due to the high cost of branded drugs, which are often unaffordable for many patients. As a result, there has been an increase in the production and distribution of generic immunosuppressants in the country.
Local special circumstances: Angola has a high burden of communicable diseases, such as malaria and tuberculosis, which has led to a focus on improving the country's healthcare system. The government has been investing heavily in the healthcare sector, including the procurement of essential medicines, such as immunosuppressants. However, there are still challenges in the distribution of these medicines to remote areas of the country.
Underlying macroeconomic factors: The growth of the immunosuppressants market in Angola is also influenced by the country's economic situation. Angola is heavily dependent on its oil exports, and the decline in oil prices in recent years has led to a decrease in government revenue. This has had an impact on the healthcare sector, with some hospitals experiencing shortages of essential medicines. However, the government has continued to prioritize healthcare spending, which has helped to mitigate some of the challenges in the sector.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
